InvestorsHub Logo
icon url

jour_trader

05/03/17 1:22 PM

#253554 RE: namtae #253552

CEO stated at last call they are annualizing at about 10M annual rate. Keep it real.
icon url

Couch

05/03/17 1:52 PM

#253560 RE: namtae #253552

LMAO total BS and Elite's 10K SEC filings prove it.

Don't worry when the next 10K comes out in June - I'll be happy to say I told you so. lol lol lol
icon url

rrr2003

05/03/17 1:57 PM

#253563 RE: namtae #253552

This is BS

Revenues will be off this year by at least $2-3million, so that kinda puts things in perspective



The Chief Financial Officer would disagree:

revenues were $2.3 million for the quarter and $8.3 million for the nine months ended December 31, 2016 and that's compared to $2.2 million and $7.3 million for the quarter and nine months of the prior-year. That's a 6% increase for the quarter as compared to last year and a 13% increase for the year-to-date as compared to last year.



ELTP is up 1 mil from the last 9 month period to this 9 month period.

https://seekingalpha.com/article/4045461-elite-pharmaceuticals-eltp-ceo-nasrat-hakim-q3-2017-results-earnings-call-transcript?part=single
icon url

lasers

05/03/17 2:37 PM

#253579 RE: namtae #253552

The 2nd shift is new and additional as well as permanent new costs commitments.

Very simple logic that equates to significant permanent manufacturing increases ongoing in 2017!